Don Frail, Vice President, AstraZeneca Innovative Medicines Group discusses the company's approach to innovation and the upcoming session at the BIO International Convention
Voyager Pauses IND Filing while Assessing Alternate Payloads for SOD1 ALS Gene Therapy Program
The company plans to assess alternate payloads for its gene therapy program, which will shift its timeline.
Podcast: Alternative Drug Delivery Methods for Biologics: Where Are We At?
This podcast explores the challenges of and the progress made so far by the biopharma industry toward alternative drug delivering methods for biologic drugs.
The 10th Anniversary of the International Day of Women and Girls in Science
Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.
Vaccines and Virus Purification through the Ages
Learn Morewww.bio-rad.com/fluvaccine
Navigating a Growing Field of New Biotherapeutic Modalities
Development of new modalities of biotherapeutic molecules will rely on manufacturing, regulatory, and collaborative support.
Grifols Teams Up with Startup, FcR Therapeutics, on Recombinant Therapies for Autoimmune Diseases
Under this early stage R&D collaboration, the companies aim to engineer recombinant biologics for blocking Fc receptors, which play a key role in autoimmune diseases.